Cargando…
Optimal treatment of actinic keratoses
The most compelling reason and primary goal of treating actinic keratoses is to prevent malignant transformation into invasive squamous cell carcinoma, and although there are well established guidelines outlining treatment modalities and regimens for squamous cell carcinoma, the more commonly encoun...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549675/ https://www.ncbi.nlm.nih.gov/pubmed/23345970 http://dx.doi.org/10.2147/CIA.S31930 |
_version_ | 1782256449003454464 |
---|---|
author | Uhlenhake, Elizabeth E |
author_facet | Uhlenhake, Elizabeth E |
author_sort | Uhlenhake, Elizabeth E |
collection | PubMed |
description | The most compelling reason and primary goal of treating actinic keratoses is to prevent malignant transformation into invasive squamous cell carcinoma, and although there are well established guidelines outlining treatment modalities and regimens for squamous cell carcinoma, the more commonly encountered precancerous actinic lesions have no such standard. Many options are available with variable success and patient compliance rates. Prevention of these lesions is key, with sun protection being a must in treating aging patients with sun damage as it is never too late to begin protecting the skin. |
format | Online Article Text |
id | pubmed-3549675 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-35496752013-01-23 Optimal treatment of actinic keratoses Uhlenhake, Elizabeth E Clin Interv Aging Review The most compelling reason and primary goal of treating actinic keratoses is to prevent malignant transformation into invasive squamous cell carcinoma, and although there are well established guidelines outlining treatment modalities and regimens for squamous cell carcinoma, the more commonly encountered precancerous actinic lesions have no such standard. Many options are available with variable success and patient compliance rates. Prevention of these lesions is key, with sun protection being a must in treating aging patients with sun damage as it is never too late to begin protecting the skin. Dove Medical Press 2013 2013-01-14 /pmc/articles/PMC3549675/ /pubmed/23345970 http://dx.doi.org/10.2147/CIA.S31930 Text en © 2013 Uhlenhake, publisher and licensee Dove Medical Press Ltd This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Review Uhlenhake, Elizabeth E Optimal treatment of actinic keratoses |
title | Optimal treatment of actinic keratoses |
title_full | Optimal treatment of actinic keratoses |
title_fullStr | Optimal treatment of actinic keratoses |
title_full_unstemmed | Optimal treatment of actinic keratoses |
title_short | Optimal treatment of actinic keratoses |
title_sort | optimal treatment of actinic keratoses |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549675/ https://www.ncbi.nlm.nih.gov/pubmed/23345970 http://dx.doi.org/10.2147/CIA.S31930 |
work_keys_str_mv | AT uhlenhakeelizabethe optimaltreatmentofactinickeratoses |